Velo3D, Inc. Stock Compensation Disclosure
Note 11. Equity Incentive Plans & Stock-Based Compensation
In 2014, the Company adopted its 2014 equity incentive plan (the “2014 Plan”) which provides for the granting of stock options, restricted stock awards and stock appreciation rights to employees, directors, and consultants of the Company.
Awards granted under the 2014 Plan generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of stock options grants shall not be less than 110% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s Board of Directors. Awards generally vest based on continuous service over four years.
Awards forfeited, cancelled, or repurchased generally are returned to the pool of shares of common stock available for issuance under the 2021 Plan (as defined below).
In 2021, the Company adopted its 2021 Equity Incentive Plan (the “2021 EIP”) which provides for the granting of stock options, restricted stock units (“RSUs”) and stock appreciation rights to employees, directors, and consultants of the Company. The Company initially reserved 81,460 shares of its common stock for issuance under the 2021 EIP. In April 2024, pursuant to the evergreen provisions of the 2021 EIP, the Company registered an additional 24,612 shares of common stock for issuance under the 2021 EIP.
As of December 31, 2025, the Company has an allocated reserve of 0 shares of its common stock for issuance under the 2021 EIP.
In addition, the Company adopted its 2021 Employee Stock Purchase Plan (“2021 ESPP”). The Company initially reserved 6,978 shares of its common stock for issuance under the 2021 ESPP. In March 2022, pursuant to the evergreen provisions of the 2021 ESPP, the Company registered an additional 3,491 shares of common stock for issuance under the 2021 ESPP.
In March 2023, pursuant to the evergreen provisions of the 2021 ESPP, the Company registered an additional 3,573 shares of common stock for issuance under the 2021 ESPP. In April 2024, pursuant to the evergreen provisions of the 2021 ESPP, the Company registered an additional 4,923 shares of common stock for issuance under the 2021 ESPP.
As of December 31, 2025, the Company has an allocated reserve of 148,787 shares of its common stock for issuance under the 2021 ESPP. As of December 31, 2025, the Company had not begun any offering periods for the 2021 ESPP.
Awards granted under the 2021 EIP generally expire 10 years from the date of grant, or earlier if services are terminated. The exercise price of stock options grants shall not be less than 110% of the estimated fair value of the shares on the date of grant, respectively, as determined by the Company’s Board of Directors. Awards generally vest based on continuous service over 4 years. Awards forfeited, cancelled, or repurchased generally are returned to the pool of shares of common stock available for issuance under the 2021 Plan.
Stock options
Activity under the Company’s stock option plans is set forth below:
|
|
Options |
|
|
Weighted-Average |
|
|
Weighted-Average |
|
|||
|
|
(In thousands) |
|
|
(Per Share Data) |
|
|
(Years) |
|
|||
Outstanding as of December 31, 2023 |
|
|
25 |
|
|
$ |
320.25 |
|
|
|
6.2 |
|
Granted |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
Exercised |
|
|
(3 |
) |
|
$ |
94.50 |
|
|
|
|
|
Forfeited or expired |
|
|
(4 |
) |
|
$ |
242.25 |
|
|
|
|
|
Outstanding as of December 31, 2024 |
|
|
18 |
|
|
$ |
380.70 |
|
|
|
5.0 |
|
Options vested and expected to vest as of December 31, 2024 |
|
|
18 |
|
|
$ |
380.70 |
|
|
|
|
|
Vested and exercisable as of December 31, 2024 |
|
|
18 |
|
|
$ |
380.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Outstanding as of December 31, 2024 |
|
|
18 |
|
|
$ |
380.70 |
|
|
|
5.0 |
|
Granted |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
Exercised |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
Forfeited or expired |
|
|
(14 |
) |
|
$ |
167.20 |
|
|
|
|
|
Outstanding as of December 31, 2025 |
|
|
4 |
|
|
$ |
1,028.92 |
|
|
|
4.4 |
|
Options vested and expected to vest as of December 31, 2025 |
|
|
4 |
|
|
$ |
1,028.92 |
|
|
|
|
|
Vested and exercisable as of December 31, 2025 |
|
|
4 |
|
|
$ |
1,028.92 |
|
|
|
|
|
As of December 31, 2025 and 2024, there is no aggregate intrinsic value of options outstanding.
Intrinsic value of options exercised for the years ended December 31, 2025 and 2024 was $0.0 million and $0.2 million, respectively. The total grant date fair value of options vested was $0.0 million and $0.1 million for the years ended December 31, 2025 and 2024, respectively.
As of December 31, 2025, there is no unrecognized compensation cost related to options.
Restricted Stock Units
The fair value of RSUs under the Company’s 2021 EIP is estimated using the value of the Company’s common stock on the date of grant.
The following table summarizes outstanding and expected to vest RSUs as of December 31, 2025 and 2024 and their activity during the year ended December 31, 2025 and 2024:
|
|
Number of Shares |
|
|
Weighted-Average |
|
|
Aggregate Intrinsic Value |
|
|||
|
|
(In thousands) |
|
|
(Per Share Data) |
|
|
(In thousands) |
|
|||
Balance as of December 31, 2023 |
|
|
38 |
|
|
$ |
1,020.00 |
|
|
$ |
7,940 |
|
Granted |
|
|
32 |
|
|
|
49.35 |
|
|
|
1,549 |
|
Released |
|
|
(38 |
) |
|
|
428.10 |
|
|
|
1,276 |
|
Cancelled |
|
|
(19 |
) |
|
|
808.65 |
|
|
|
1,050 |
|
Balance as of December 31, 2024 |
|
|
13 |
|
|
$ |
714.30 |
|
|
$ |
132 |
|
Expected to vest as of December 31, 2024 |
|
|
13 |
|
|
$ |
714.30 |
|
|
$ |
132 |
|
|
|
|
|
|
|
|
|
|
|
|||
Balance as of December 31, 2024 |
|
|
13 |
|
|
$ |
714.30 |
|
|
$ |
132 |
|
Granted |
|
|
1,438 |
|
|
|
17.20 |
|
|
|
24,743 |
|
Released |
|
|
(288 |
) |
|
|
25.12 |
|
|
|
1,622 |
|
Cancelled |
|
|
(133 |
) |
|
|
21.04 |
|
|
|
1,212 |
|
Balance as of December 31, 2025 |
|
|
1,030 |
|
|
$ |
22.42 |
|
|
$ |
14,158 |
|
Expected to vest as of December 31, 2025 |
|
|
1,030 |
|
|
$ |
22.42 |
|
|
$ |
14,158 |
|
The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding. As of December 31, 2025, there was $21.1 million of unrecognized compensation cost, which is expected to be recognized over a weighted average period of approximately 3.2 years.
Earnout Shares - Employees
The Earnout Shares issuable to holders of employee stock options are accounted as stock-based compensation expense as they are subject to forfeiture based on the satisfaction of certain employment conditions. The estimated fair values of the Earnout Shares associated with vested stock options are recognized as an expense and determined by the Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the five-year earnout period. The portion of the Earnout Shares associated with unvested stock options are recognized as an expense and considers the vesting continuing employment requirements.
Stock-based Compensation Expense
The following sets forth the total stock-based compensation expense by type of award included in operating expenses on the statements of operations:
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
|
|
(In thousands) |
|
|||||
Restricted stock units |
|
$ |
9,504 |
|
|
$ |
11,281 |
|
Stock options |
|
|
5 |
|
|
|
125 |
|
Earnout shares — employees |
|
|
— |
|
|
|
404 |
|
|
|
$ |
9,509 |
|
|
$ |
11,810 |
|
The following sets forth the total stock-based compensation expense for the stock options, RSUs, and earnout shares - employees included in operating expenses on the statements of operations:
|
|
December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
|
|
(In thousands) |
|
|||||
Cost of 3D Printer and parts |
|
$ |
1,518 |
|
|
$ |
999 |
|
Cost of Support services |
|
|
526 |
|
|
|
649 |
|
Stock-based compensation recorded in cost of revenue |
|
|
2,044 |
|
|
|
1,648 |
|
Research and development |
|
|
1,987 |
|
|
|
2,630 |
|
Selling and marketing |
|
|
1,030 |
|
|
|
1,758 |
|
General and administrative |
|
|
4,448 |
|
|
|
5,774 |
|
Stock-based compensation recorded in operating expense |
|
|
7,465 |
|
|
|
10,162 |
|
Total stock-based compensation expense |
|
$ |
9,509 |
|
|
$ |
11,810 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 31, 2025 | |
| 2023 | Apr 3, 2024 | |
| 2022 | Mar 20, 2023 | |
| 2021 | Mar 28, 2022 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.